BioSpace News Archive

Dr John Prendergast will showcase the potential of New Synthetic Antibiotics

AZTherapies, Inc. announced that it has completed target enrollment in its COGNITE Phase 3 clinical trial, evaluating the safety and efficacy of ALZT-OP1 for the treatment of early Alzheimer’s disease.

Evotec SE and Lygature announced their cooperation in a new initiative for the development of novel antibacterial agents.

Almac Clinical Services, part of the global contract pharmaceutical development and manufacturing organization the Almac Group, is delighted to invite participants from the Biopharma industry to join its Souderton Lunch and Learn Workshop on Wednesday, September 18.

Largest Customer Confirms Conversion Timetable & Provides Full-Scale Order

FUJIFILM Corporation announced that it has completed the acquisition of Biogen Manufacturing ApS, a large-scale biologics manufacturing site located in Hillerød near Copenhagen, Denmark from Biogen.

Ultragenyx Pharmaceutical Inc. reported its financial results and corporate update for the quarter ended June 30, 2019.

Adaptimmune announced several changes to its executive leadership team. Perhaps the biggest news is that Rafael Amado, president of R&D, is leaving the company “to pursue other opportunities.”

Clinical stage cannabinoid company Botanix Pharmaceuticals Limited is pleased to announce the receipt of firm commitments in respect of a A$40m placement led by specialist US-based biotech investment funds and leading US institutional investors, as well as the appointment of two new experienced dermatology executives.

Biological Specialty Company (BSC), a leading provider of human blood products and biological specimens to the research community, today announced the introduction of a series of enhancements to the donor experience at its centers in Colmar, Allentown and Reading, PA.